Sphera Funds Management Ltd. Amylyx Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.71 $374,544 - $626,552	-231,200 Reduced 86.51%	36,050 $68,000
Q1 2024 May 15, 2024	BUY	$2.71 - $19.57 $226,556 - $1.64 Million	83,600 Added 45.52%	267,250 $758,000
Q4 2023 Feb 14, 2024	SELL	$12.07 - $18.46 $120,700 - $184,600	-10,000 Reduced 5.16%	183,650 $2.7 Million
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $1.69 Million - $2.2 Million	93,650 Added 93.65%	193,650 $3.55 Million
Q2 2023 Aug 14, 2023	BUY	$20.98 - $31.42 $2.1 Million - $3.14 Million	100,000 New	100,000 $2.16 Million

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.